|
|||||
|
|
Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications |
|
| Affiliation: | 1. Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA;2. Sinai Health System, Department of Medicine, University of Toronto, Toronto, Ontario, Canada;3. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA |
| Abstract: | |
| Keywords: | diabetes drug prices outcomes-based contracts |
| 本文献已被 ScienceDirect 等数据库收录！ | |